Ivermectin kills several types of parasitic worms in dogs, but its primary FDA-approved use is preventing heartworm disease caused by Dirofilaria immitis. Beyond heartworm, it is effective against certain hookworms, roundworms, and the mites that cause mange, though many of these uses are technically off-label. Here’s a breakdown of what ivermectin targets and how it works.
How Ivermectin Kills Parasites
Ivermectin works by forcing open chloride channels in the nerve and muscle cells of parasites. These channels are found in invertebrates but not in mammals, which is why the drug can kill worms without harming your dog at appropriate doses. Once those channels lock open, the parasite’s muscles become permanently relaxed. Depending on where the drug acts, it can shut down a worm’s ability to feed by paralyzing its throat muscles, stop it from moving through the body, or prevent females from releasing eggs and larvae. It also blocks the parasite’s ability to suppress your dog’s immune system, making it easier for the body to clear the infection on its own.
Heartworm Larvae
The FDA-approved indication for ivermectin in dogs is preventing heartworm disease. Products like Heartgard work by eliminating the immature tissue-stage larvae of Dirofilaria immitis within 30 days of infection. Given monthly, ivermectin kills these larvae before they can mature into adult worms that live in the heart and pulmonary arteries. It does not reliably kill adult heartworms already established in the heart, so it functions as prevention rather than treatment for an active infection.
Hookworms
Ivermectin-based products control hookworm species that commonly infect dogs, including Ancylostoma caninum (the most common canine hookworm) and Uncinaria stenocephala, a species more prevalent in cooler climates. Many monthly heartworm preventives combine ivermectin with pyrantel, which broadens their hookworm coverage. Ivermectin has also been used in pregnant dogs shortly before and after whelping to reduce the transmission of hookworm larvae to puppies through the mother’s milk.
One important caveat: multidrug-resistant hookworms have emerged in the southeastern United States. These Ancylostoma caninum strains resist all three major drug classes approved for hookworm treatment in dogs, including ivermectin. If your dog has persistent hookworm infections despite regular treatment, resistance may be the reason.
Roundworms
Ivermectin has activity against common canine roundworms (Toxocara canis and Toxascaris leonina), though it is typically combined with other active ingredients for broader intestinal parasite coverage. Most combination heartworm preventives pair ivermectin with pyrantel (for roundworms and hookworms) or with both pyrantel and praziquantel (which adds tapeworm coverage). Ivermectin alone at heartworm-prevention doses is not considered a standalone roundworm treatment.
Mange Mites
Though not FDA-approved for this purpose, ivermectin is widely used off-label to treat two types of mange in dogs.
Sarcoptic Mange
Sarcoptic mange is caused by Sarcoptes scabiei, a burrowing mite that triggers intense itching. Ivermectin is considered very effective and usually curative for this condition, typically given as two to four treatments spaced two weeks apart.
Demodectic Mange
Demodectic mange, caused by Demodex canis, requires a more aggressive approach. Treatment involves daily oral dosing over weeks, with the dose gradually increased while the dog is monitored for side effects. This protocol uses significantly higher doses than heartworm prevention, which increases the risk of toxicity.
What Ivermectin Does Not Cover Well
Ivermectin at standard heartworm-prevention doses does not effectively treat whipworms (Trichuris vulpis), one of the most common intestinal parasites in dogs. It also does not kill tapeworms. If your dog needs protection against these parasites, your vet will typically recommend a product that includes additional active ingredients or a different dewormer entirely.
Breed Sensitivity and Safety
Certain breeds carry a genetic variant called MDR1 that makes them far more sensitive to ivermectin. This variant is most common in herding breeds: Collies, Australian Shepherds, Shetland Sheepdogs, Old English Sheepdogs, and German Shepherds, among others. In dogs with this mutation, higher doses of ivermectin can cross into the brain and cause serious neurological symptoms, including loss of coordination, drooling, weakness, dilated pupils, apparent blindness, slow heart rate, and difficulty breathing.
The key distinction is dose. Monthly heartworm preventives use very low doses of ivermectin that remain safe even for MDR1-sensitive dogs. The danger arises with the much higher doses used off-label for mange treatment or when a dog accidentally ingests livestock-strength ivermectin products. Genetic testing for the MDR1 variant is available and worth considering before any higher-dose ivermectin use, regardless of breed, since the mutation occasionally appears in mixed-breed dogs as well.